Kato M, Ota H, Okuda M, Kikuchi S, Satoh K, Shimoyama T, Suzuki H, Handa O, Furuta T, Mabe K et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2016 revised edition. Helicobacter 2019, 24(4):e12597.
Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784–9.
Google Scholar
IARC Helicobacter pylori Working Group. Helicobacter pylori eradication as a strategy for preventing gastric cancer (IARC Working Group Report Volume 8). Lyon, France: International Agency for Research on Cancer; 2014.
Health, Labour and Welfare Statistics Association. 国民衛生の動向 2024/2025. J Health Welfare Stat. 2024;71(9):1–412.
Correa P. Human gastric carcinogenesis: a multistep and multifactorial process–first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res. 1992;52(24):6735–40.
Google Scholar
Schlemper RJ, van der Werf SD, Biemond I, Lamers CB. Seroepidemiology of gastritis in Japanese and Dutch male employees with and without ulcer disease. Eur J Gastroenterol Hepatol. 1996;8(1):33–9.
Google Scholar
Schultze V, Hackelsberger A, Gunther T, Miehlke S, Roessner A, Malfertheiner P. Differing patterns of Helicobacter pylori gastritis in patients with duodenal, prepyloric, and gastric ulcer disease. Scand J Gastroenterol. 1998;33(2):137–42.
Google Scholar
El-Zimaity HMT, Gutierrez O, Kim JG, Akamatsu T, Gurer IE, Simjee AE, Graham DY. Geographic differences in the distribution of intestinal metaplasia in duodenal ulcer patients. Am J Gastroenterol. 2001;96(3):666–72.
Google Scholar
Kamada T, Hata J, Sugiu K, Kusunoki H, Ito M, Tanaka S, Inoue K, Kawamura Y, Chayama K, Haruma K. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan. Aliment Pharmacol Ther. 2005;21(9):1121–6.
Google Scholar
Tahara T, Shibata T, Horiguchi N, Kawamura T, Okubo M, Ishizuka T, Nagasaka M, Nakagawa Y, Ohmiya N. A possible link between gastric mucosal atrophy and gastric cancer after Helicobacter pylori eradication. PLoS One. 2016;11(10): e0163700.
Google Scholar
Adachi K, Kishi K, Sakamoto U, Ishimura N, Ishihara S. Degree of gastric mucosal atrophy correlated well with gastric cancer occurrence in patients with Helicobacter pylori-eradicated status. Intern Med. 2023;62(10):1389–94.
Google Scholar
Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, Oguma K, Okada H, Shiratori Y. The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol. 2005;100(5):1037–42.
Google Scholar
Kishikawa H, Ojiro K, Nakamura K, Katayama T, Arahata K, Takarabe S, Miura S, Kanai T, Nishida J. Previous Helicobacter pylori infection–induced atrophic gastritis: a distinct disease entity in an understudied population without a history of eradication. Helicobacter. 2020;25(1): e12669.
Google Scholar
人を対象とする生命科学・医学系研究に関する倫理指針ガイダンス (日本語) (Revised: 令和6年4月1日) [https://www.mhlw.go.jp/content/001237478.pdf]
Projected cancer incidence in 2023 [https://ganjoho.jp/reg_stat/statistics/stat/short_pred_en.html]
Sugano K, Moss SF, Kuipers EJ. Gastric intestinal metaplasia: real culprit or innocent bystander as a precancerous condition for gastric cancer? Gastroenterology. 2023;165(6):1352–66.e1351.
Google Scholar
Rugge M, Meggio A, Pravadelli C, Barbareschi M, Fassan M, Gentilini M, Zorzi M, Pretis G, Graham DY, Genta RM. Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients. Gut. 2019;68(1):11–7.
Google Scholar
Shichijo S, Hirata Y, Niikura R, Hayakawa Y, Yamada A, Ushiku T, Fukayama M, Koike K. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication. Gastrointest Endosc. 2016;84(4):618–24.
Google Scholar
Take S, Mizuno M, Ishiki K, Kusumoto C, Imada T, Hamada F, Yoshida T, Yokota K, Mitsuhashi T, Okada H. Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication. J Gastroenterol. 2020;55(3):281–8.
Google Scholar
Karita M, Noriyasu A, Kosako E, Teramukai S, Matsumoto S. Relationship between pepsinogen I&II and H. pylori infection considered with grade of atrophy and gastroduodenal diseases. Dig Dis Sci. 2003;48(9):1839–45.
Hwang JJ, Lee DH, Lee AR, Yoon H, Shin CM, Park YS, Kim N. Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection. World J Gastroenterol. 2015;21(16):4954–60.
Google Scholar
Shichijo S, Uedo N, Michida T. Detection of early gastric cancer after Helicobacter pylori eradication. Digestion. 2022;103(1):54–61.
Google Scholar
Take S, Mizuno M, Ishiki K, Yoshida T, Ohara N, Yokota K, Oguma K, Okada H, Yamamoto K. The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori. J Gastroenterol. 2011;46(3):318–24.
Google Scholar
Sugano K. Effect of Helicobacter pylori eradication on the incidence of gastric cancer: a systematic review and meta-analysis. Gastric Cancer. 2019;22(3):435–45.
Google Scholar
Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, Graham DY. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology. 2016;150(5):1113–24.e1115.
Google Scholar
Ford AC, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis. Gut. 2020;69(12):2113–21.
Google Scholar
Ford AC, Yuan Y, Moayyedi P. Long-term impact of Helicobacter pylori eradication therapy on gastric cancer incidence and mortality in healthy infected individuals: a meta-analysis beyond 10 years of follow-up. Gastroenterology. 2022;163(3):754–6.e751.
Google Scholar
Pimenta-Melo AR, Monteiro-Soares M, Libanio D, Dinis-Ribeiro M. Missing rate for gastric cancer during upper gastrointestinal endoscopy: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2016;28(9):1041–9.
Google Scholar
Ono S, Kawada K, Dohi O, Kitamura S, Koike T, Hori S, Kanzaki H, Murao T, Yagi N, Sasaki F, et al. Linked color imaging focused on neoplasm detection in the upper gastrointestinal tract : a randomized trial. Ann Intern Med. 2021;174(1):18–24.
Google Scholar
Kobayashi M, Nishioji K, Kamaguchi M. Recommendations for stomach cancer screening during Helicobacter pylori eradication era [in Japanese]. Journal of Gastrointestinal Cancer Screening. 2019;57(6):1114–27.
Hansson LE, Nyren O, Hsing AW, Bergstrom R, Josefsson S, Chow WH, Fraumeni JF Jr, Adami HO. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med. 1996;335(4):242–9.
Google Scholar
Kato M, Ono S, Mori Y, Nakagawa M, Mabe K, Kudo T. Characteristics of gastric cancer after eradication of Helicobacter pylori – from a clinical point of view [in Japanese]. Stomach Intestine. 2012;47(11):1640–8.
Okada K, Suzuki S, Naito S, Yamada Y, Haruki S, Kubota M, Nakajima Y, Shimizu T, Ando K, Uchida Y et al. Incidence of metachronous gastric cancer in patients whose primary gastric neoplasms were discovered after Helicobacter pylori eradication. Gastrointest Endosc. 2019;89(6):1152–9.e1151.
Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med. 2018;378(12):1085–95.
Google Scholar
Nishizawa T, Suzuki H, Arano T, Yoshida S, Yamashita H, Hata K, Kanai T, Yahagi N, Toyoshima O. Characteristics of gastric cancer detected within 1 year after successful eradication of Helicobacter pylori. J Clin Biochem Nutr. 2016;59(3):226–30.
Google Scholar
Fiddian-Green RG, Bank S, Marks IN, Louw JH. Maximum acid output and position of peptic ulcers. Lancet. 1976;2(8000):1370–3.
Google Scholar
Oi M, Oshida K, Sugimura S. The location of gastric ulcer. Gastroenterology. 1959;36(1):45–56.
Google Scholar
Rumball JM. Chapter 7 – Coexistent duodenal ulcer. Gastroenterology. 1971;61(4):622–7.
Oi M. Peptic ulcer and gastric acidity: a new look at an old aphorism, “the higher the ulcer, the lower the acidity.” J Gastroenterol. 1995;30(1):122–7.
Google Scholar
Tatsuta M, Iishi H, Okuda S. Location of peptic ulcers in relation to antral and fundal gastritis by chromoendoscopic follow-up examinations. Dig Dis Sci. 1986;31(1):7–11.
Google Scholar
Wu MS, Wang HP, Wang JT, Wang TH, Lin JT. Serum pepsinogen I and pepsinogen II, and the ratio of pepsinogen I/pepsinogen II in peptic ulcer diseases: with special emphasis on the influence of the location of the ulcer crater. J Gastroenterol Hepatol. 1995;10(4):401–4.
Google Scholar
Mori H, Suzuki H, Omata F, Masaoka T, Asaoka D, Kawakami K, Mizuno S, Kurihara N, Nagahara A, Sakaki N, et al. Current status of first- and second-line Helicobacter pylori eradication therapy in the metropolitan area: a multicenter study with a large number of patients. Therap Adv Gastroenterol. 2019;12:1756284819858511.
Google Scholar
Howden CW, Cook EE, Swallow E, Yang K, Guo H, Pelletier C, Jacob R, Sugano K. Real-world outcomes associated with vonoprazan-based versus proton pump inhibitor-based therapy for Helicobacter pylori infection in Japan. Therap Adv Gastroenterol. 2023;16:17562848231168714.
Google Scholar
Hiroi S, Sugano K, Tanaka S, Kawakami K. Impact of health insurance coverage for Helicobacter pylori gastritis on the trends in eradication therapy in Japan: retrospective observational study and simulation study based on real-world data. BMJ Open. 2017;7(7): e015855.
Google Scholar
Tokunaga K, Suzuki C, Hasegawa M, Fujimori I. Cost analysis in Helicobacter pylori eradication therapy based on a database of health insurance claims in Japan. Clinicoecon Outcomes Res. 2021;13:241–50.
Google Scholar